RU2003117016A - Способ получения латентного антитромбина iii - Google Patents

Способ получения латентного антитромбина iii Download PDF

Info

Publication number
RU2003117016A
RU2003117016A RU2003117016/13A RU2003117016A RU2003117016A RU 2003117016 A RU2003117016 A RU 2003117016A RU 2003117016/13 A RU2003117016/13 A RU 2003117016/13A RU 2003117016 A RU2003117016 A RU 2003117016A RU 2003117016 A RU2003117016 A RU 2003117016A
Authority
RU
Russia
Prior art keywords
range
concentration
buffer
antithrombin iii
sulfate ions
Prior art date
Application number
RU2003117016/13A
Other languages
English (en)
Russian (ru)
Inventor
Йеран КАРЛССОН (SE)
Йеран КАРЛССОН
Original Assignee
Октафарма АГ (CH)
Октафарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Октафарма АГ (CH), Октафарма Аг filed Critical Октафарма АГ (CH)
Publication of RU2003117016A publication Critical patent/RU2003117016A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8128Antithrombin III
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
RU2003117016/13A 2000-11-08 2001-11-08 Способ получения латентного антитромбина iii RU2003117016A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0004086-5 2000-11-08
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
US60/252,148 2000-11-20

Publications (1)

Publication Number Publication Date
RU2003117016A true RU2003117016A (ru) 2004-12-10

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003117016/13A RU2003117016A (ru) 2000-11-08 2001-11-08 Способ получения латентного антитромбина iii

Country Status (15)

Country Link
EP (1) EP1332159A1 (cs)
JP (1) JP2004522707A (cs)
KR (1) KR20030057545A (cs)
AU (1) AU2002214468A1 (cs)
BR (1) BR0115188A (cs)
CA (1) CA2428055A1 (cs)
CZ (1) CZ20031277A3 (cs)
EE (1) EE200300218A (cs)
HU (1) HUP0301766A3 (cs)
IL (1) IL155539A0 (cs)
MX (1) MXPA03004030A (cs)
NO (1) NO20032048D0 (cs)
PL (1) PL360410A1 (cs)
RU (1) RU2003117016A (cs)
WO (1) WO2002038610A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
PL1848473T3 (pl) 2005-02-07 2013-11-29 Hanuman Llc Urządzenie - koncentrator osocza
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2146794B1 (en) 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
CA2428055A1 (en) 2002-05-16
JP2004522707A (ja) 2004-07-29
HUP0301766A2 (hu) 2003-08-28
CZ20031277A3 (cs) 2003-08-13
HUP0301766A3 (en) 2005-12-28
AU2002214468A1 (en) 2002-05-21
BR0115188A (pt) 2004-02-03
NO20032048L (no) 2003-05-07
NO20032048D0 (no) 2003-05-07
IL155539A0 (en) 2003-11-23
EP1332159A1 (en) 2003-08-06
EE200300218A (et) 2003-08-15
MXPA03004030A (es) 2004-02-12
KR20030057545A (ko) 2003-07-04
PL360410A1 (en) 2004-09-06
WO2002038610A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
DK1140156T3 (da) Oprensning af konjugerede polysaccharidproteinvacciner ved hjælp af ultrafiltrering med ammoniunmsulfatoplösninger
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
EP1044054A4 (en) Electrolytic process for treating aqueous waste streams
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
PT702085E (pt) Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
EP1324780A4 (en) METHODS OF TREATING CARDIAC ARRHYTHMIA
DE60143672D1 (de) Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation
BR9407138A (pt) Método para esterilização de produtos
NO954428D0 (no) Rensing av plasmaproteiner
CY1107632T1 (el) Διαδικασια για την παρασκευη μιας θρομβινης στην οποια εχουν αδρανοποιηθει οι ιοι
ATE198867T1 (de) Verfahren zur behandlung von rauchgasen auf basis von schwefeloxiden
BR0115188A (pt) Processo para a preparação de antitrombina iii latente
ATE208765T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
DE60131545D1 (de) Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
BR9913009A (pt) Processo para tratamento de água de circulação de uma linha de esmaltação
NO960377D0 (no) Hellbare vaskemiddelkonsentrater med uendret eller öket viskositet ved fortynning med vann, og fremgangsmåte for fremstilling av slike
DE59906097D1 (de) Verfahren zur herstellung wässriger, im wesentlichen metallionenfreier hydroxylaminlösungen
AU2002359327A1 (en) Method of treating viral infections
FR2792309B1 (fr) Procede d'elimination des legionella d'un flux aqueux colonise par electropulsation, procede de traitement d'un flux aqueux par electropulsation, et application a l'elimination des legionella
FI20010475L (fi) Menetelmä kalsiumin poistamiseksi sinkkiprosessin sulfaattiliuoksista
CA2402057A1 (en) Process for purifying aqueous buffer solutions

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20050301